Literature DB >> 14612501

Power law distribution of chromosome aberrations in cancer.

Attila Frigyesi1, David Gisselsson, Felix Mitelman, Mattias Höglund.   

Abstract

Cancer cells are characterized by having aberrant chromosomes. The number of aberrations and the specific chromosomes affected are correlated with tumor progression. We show that for breast, colorectal, and renal cell carcinomas the distribution of the number of such aberrations per tumor follow a power law distribution with an exponent close to unity. We present two stochastic models that in simulation experiments result in power law distributions of the number of changes per tumor. The first model is based on a multiplicative fluctuation process and the second on a preferential attachment principle linked to an observation process, i.e., a tumor detection and treatment process. Because almost identical power law distributions are seen in breast, colorectal, and renal cell carcinomas we suggest that the obtained distributions are consequences of a common mechanism operating in malignant epithelial tumors.

Entities:  

Mesh:

Year:  2003        PMID: 14612501

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Modeling the effect of tumor size in early breast cancer.

Authors:  Claire Verschraegen; Vincent Vinh-Hung; Gábor Cserni; Richard Gordon; Melanie E Royce; Georges Vlastos; Patricia Tai; Guy Storme
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

2.  The birth-death-mutation process: a new paradigm for fat tailed distributions.

Authors:  Yosef E Maruvka; David A Kessler; Nadav M Shnerb
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

3.  Elevated tolerance to aneuploidy in cancer cells: estimating the fitness effects of chromosome number alterations by in silico modelling of somatic genome evolution.

Authors:  Anders Valind; Yuesheng Jin; David Gisselsson
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.